NK cells naturally target multiple antigens by binding the conserved crystallizable fragment (Fc) of IgG, unlike chimeric antigen receptor (CAR)–T cells or CAR–NK cells that are programmed to recognize a single antigen.A, NK cell Fc γ receptor IIIa/CD16a associates with either CD3ζ or the Fc ε receptor γ chain to activate an NK cell after ligation to an antibody-bound target (70, 71). The CAR-T example shown represents the tisagenlecleucel (Kymriah) therapy that targets CD19 on B-cell lymphoma. This CAR–NK construct likewise recently showed success (3, 72). Both CARs contain custom transmembrane and activation domains. B, Fc γ receptors bind to the crystallizable fragment of IgG. IgG, immunoglobulin G; NK, natural killer.